References
- Welch HG, Black WC. Using autopsy series to estimate the disease “reservoir” for ductal carcinoma in situ of the breast: how much more breast Cancer can we find? Ann Internl Med 1997; 127 (11):1023-28; https://doi.org/10.7326/0003-4819-127-11-199712010-00014
- Zlotta AR, Egawa S, Pushkar D, Govorov A, Kimura T, Kido M, Takahashi H, Kuk C, Kovylina M, Aldaoud N, et al. Prevalence of Prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men. 2013. J Natl Cancer Inst 2013; 17 105 (14):1050-58; https://doi.org/10.1093/jnci/djt151
- Kudrin and Hanna. Overview of the cancer vaccine field: Are we moving forward? Hum Vaccin Immunother 2012; 8:1135-44; PMID:22854670; https://doi.org/10.4161/hv.20474
- Pardoll DM. The blockade of tumor checkpoints in cancer. Nat Rev Cancer 2012; 12:252-64; PMID:22437870; https://doi.org/10.1038/nrc3239
- Dimond PF. Intratumor heterogeneity poses challenge for cancer “moonshot” program. Gen Exclusive 2016; 36(5).
- Ling S, Hu Z, Yang Z, Yang F, Li Y, Lin P, Chen 1<, Cao L, Tao Y, Hao L, et al. Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution. PNAS 2015; 112:E6496-6505; PMID:26561581; https://doi.org/10.1073/pnas.1519556112
- Tannock IF, and Hickman JH. Limits to Personalized Cancer Medicine. N Engl J Med 375 2016; 13:1281-94.
- Wood L. The Genomic Landscapes of Human Breast and Colorectal Cancers. Science 2007; 318:1108-13; PMID:17932254; https://doi.org/10.1126/science.1145720
- Dunn GP, Old 1J, Schreiber R. The Immunobiology of Cancer Immunosurvellance and Immunoediting Immunity. Aug 2004; 21 (2):137-148.
- Schreiber RD, Old LJ, Smyth MJ. Cancer Immunoediting: Integrating immunity's roles in cancer suppression and promotion. Science 2011; 331:1565-70; PMID:21436444; https://doi.org/10.1126/science.1203486
- Adler FL. Antibody formation after injection of heterologous immune globulin Il Competition of Antigens. J Immun 1957; 78 (3):201-10; PMID:13429087
- Eidinger D, Khan SA, Millar KG. The effect of antigenic competition on various manifestations of humoral antibody formation and cellular immunity. J Exp Med 1968; 128:1183-200; PMID:5696281; https://doi.org/10.1084/jem.128.5.1183
- Hanna Jr„ MG, Peters LC. The effect of antigen competition on both the primary and secondary immune capacity in mice. J Immun 1970; 104 (1):166-177; PMID:4189099
- Muschaweckh A, Bucholz VR, Fellenzer A, Hessel C, Konig PA, Tao S, Roony T, Heikenwilder M, Bush DH, Korn T, et al. Antigen-dependent competition shapes the local repertoire of tissue-resident memory CD8+ T cells. JEM 2016; 213 (No. 13):3075-86; https://doi.org/10.1084/jem.20160888
- Hanna Jr. MG, Peters LC. Morphological and functional aspects of active-specific immunotherapy of estaqblished pulmonary metastasis in guinea pigs. Cancer Res 1981; 41:4001-6; PMID:7285011
- Fidler IJ, Hanna Jr. MG. New approaches to specific and nonspecific immunotherapy of established cancer metastasis. Published in Fundamentasl Mechanisms in Human Cancer immunotherapy, Saunders, Daniels, Serrou, Rosenfeld and Denny Eds, Elsevier North Holland, Inc., 1981, pps 425-437.
- VermorkenJB C, vanTinterenH G, Ezinga R, Meijer S, Scheper RJ, Meijer CJLM, Bloemena E, Ransom JH, Hanna Jr. MG, Pinedo H. Active specific immunotherapy for stage Il and stage Ill human colon cancer: a randomised trial. Lancet 1999; 353:345-50; PMID:9950438; http://dx. doi.org/10.1016/S0140-6736(98)07186-4
- Hanna Jr. MG, Howard J, Vermorken J. Active specific immunotherapy:Using tumor heterogeneity to successfully fight cancer. Hum Vaccines and Immunotherapy 2014; 10 (11):3286-96; https://doi.org/10.4161/hv.28886
- de Weger VA, Turksma AW, Voorham QJ, Euler Z, Bril H, van den Eertwegh AJ, Bloemena E. Clinical effects of adjuvant active specific immunotherapy differ between patients with microsatellite stable and micro- satellite instable colon cancer. Clin Cancer 2012; 18(3):882-889
- Haspel MV, McCabe RP, Pomato N, Janesch NJ, Knowlton JV, Peters LC, Hoover HC Jr., Hanna MG Jr.. Generation of tumor cell-reactive human monoclonal antibodies using peripheral blood lymphocytes from actively immunized colorectal carcinoma patients. Cancer Res 1985; 45:3951-61; PMID:4016762